Cite
HARVARD Citation
Ruicci, K. et al. (2019). A controlled trial of HNSCC patient‐derived xenografts reveals broad efficacy of PI3Kα inhibition in controlling tumor growth. International journal of cancer. 145 (8), pp. 2100-2106. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ruicci, K. et al. (2019). A controlled trial of HNSCC patient‐derived xenografts reveals broad efficacy of PI3Kα inhibition in controlling tumor growth. International journal of cancer. 145 (8), pp. 2100-2106. [Online].